Details for Patent: 6,046,202
✉ Email this page to a colleague
Summary for Patent: 6,046,202
Title: | Use of thiazolidinedione derivatives in the treatment of insulin resistance |
Abstract: | The present invention provides methods of using thiazolidinedione in the treatment of insulin resistance. |
Inventor(s): | Antonucci; Tammy (Thousand Oaks, CA), Lockwood; Dean (Ann Arbor, MI), Norris; Rebecca (Kewadin, MI) |
Assignee: | Warner-Lambert Company (Morris Plains, NJ) |
Application Number: | 09/168,515 |
Patent Claim Types: see list of patent claims | Use; | More… ↓ |
Drugs Protected by US Patent 6,046,202
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,046,202
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 198045 | ⤷ Subscribe | |||
Austria | 303147 | ⤷ Subscribe | |||
Austria | 376829 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |